What You Should Know
- The Funding: Amigo AI secures $11M in Series A funding round led by Madrona, with participation from Optum Ventures. This brings the company’s total capital raised to $17M.
- AI Clinical Agents: While many healthcare AI startups focus on back-office ambient scribes, Amigo builds and trains autonomous patient-facing clinical agents. These agents interact directly with patients for intake, triage, personalized care navigation, and 24/7 support.
- The “Digital Residency”: To mitigate the immense liability of patient-facing AI, Amigo does not let general-purpose LLMs interact with patients. Instead, agents must complete a “digital residency”—training across millions of simulated, practice-specific edge cases and adversarial scenarios until they reach a 100% safety pass rate.
- The Traction: In the last six months, Amigo agents have completed over 3 million patient encounters globally for organizations like Eucalyptus and Diverge Health, with zero reported safety incidents.
- The Clinical Leadership: Further signaling its commitment to clinical rigor, Amigo recently appointed Dr. Jay Shah, Chief of the Medical Staff at Stanford Health Care, as its Chief Medical Advisor.
The Algorithm Goes to Med School
If a health system deploys a generic “wrapper” of ChatGPT to triage its patients, it is asking for a malpractice lawsuit. General-purpose large language models (LLMs) are prone to hallucination and lack the rigid cognitive guardrails required for clinical escalation.
Amigo AI approaches this architectural flaw through a concept it calls the “Digital Residency.” “We train our agents like doctors because mistakes can cost lives in healthcare,” explained Ali Khokhar, Founder and CEO of Amigo. “No agent should interact with a real patient until it’s been rigorously trained and proven safe.”
Before an Amigo agent is ever deployed, it is subjected to millions of simulated scenarios modeled specifically on the deploying practice’s unique patient population. The system deliberately over-indexes on adversarial patients and edge cases. The AI is continuously tested on its accuracy, empathy, and harm prevention, and it is entirely walled off from live deployment until it achieves a flawless 100% safety pass rate.
Furthermore, the architecture mimics human care teams. Multiple Amigo agents share unified patient context in real time—drawing directly from native integrations with Epic, Oracle Health, and Athenahealth—ensuring that complex handoffs occur seamlessly without information loss.
Scale Without Compromise
The theoretical promise of the “Digital Residency” is backed by staggering real-world execution. In just the last six months, Amigo has quietly powered over 3 million autonomous patient encounters across the globe with zero safety incidents.
To ensure the technology continues to meet the highest clinical standards, the company appointed Dr. Jay Shah, Chief of the Medical Staff at Stanford Health Care, as its Chief Medical Advisor. “Amigo’s approach of training agents with the same rigor we expect of clinicians means they can operate at the standard I’ve seen at Stanford, Columbia, and MD Anderson,” Dr. Shah noted.
